课题基金 / 基金详情

Assessment of Midodrine in the Prevention of Vasovagal Syncope (POST 4)

Assessment of Midodrine in the Prevention of Vasovagal Syncope (POST 4)
米多君预防血管迷走性晕厥的评估(POST 4)
批准号:
223187
负责人:
Sheldon Robert S
金额:
$41.55万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-03-01 至 2016-03-01

项目摘要

项目成果

Sheldon Robert S的其他基金

相似基金

相关文献

中文摘要
翻译
昏厥影响了大约50%的加拿大人,是1-2%急诊室就诊的原因,每年可能造成2.5亿美元的医疗支出。经常晕厥会导致生活质量下降,在工作、家庭和开车时也会出现问题。
英文摘要
Fainting affects about 50% of Canadians, is the cause of 1-2% of emergency room visits, and probably causes $250 million in health care spending each year. Frequent fainting causes a poor quality of life, and problems at work, at home, and while driving.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Randomized, Prospective, Placebo-Controlled, Crossover Study of Atomoxetine in the Prevention of Vasovagal Syncope: The Seventh Prevention of Syncope Trial (POST7)
  • 批准号:
    444488
  • 项目类别:
    Operating Grants
  • 资助金额:
    $61.3万
  • 财政年份:
    2021
  • 负责人:
    Sheldon Robert S
  • 依托单位:
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects (POST5)
  • 批准号:
    279562
  • 项目类别:
    Operating Grants
  • 资助金额:
    $59.12万
  • 财政年份:
    2013
  • 负责人:
    Sheldon Robert S
  • 依托单位:
Syncope: Pacing or Recording in the Later Years (SPRITELY)
  • 批准号:
    210753
  • 项目类别:
    Operating Grants
  • 资助金额:
    $48.09万
  • 财政年份:
    2010
  • 负责人:
    Sheldon Robert S
  • 依托单位:
海外基金